Fitness Costs and Diversity of the Cytotoxic T Lymphocyte (CTL) Response Determine the Rate of CTL Escape during Acute and Chronic Phases of HIV Infection
出版年份 2011 全文链接
标题
Fitness Costs and Diversity of the Cytotoxic T Lymphocyte (CTL) Response Determine the Rate of CTL Escape during Acute and Chronic Phases of HIV Infection
作者
关键词
-
出版物
JOURNAL OF VIROLOGY
Volume 85, Issue 20, Pages 10518-10528
出版商
American Society for Microbiology
发表日期
2011-08-11
DOI
10.1128/jvi.00655-11
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Killing of Targets by CD8+ T Cells in the Mouse Spleen Follows the Law of Mass Action
- (2011) Vitaly V. Ganusov et al. PLoS One
- Taking Multiple Infections of Cells and Recombination into Account Leads to Small Within-Host Effective-Population-Size Estimates of HIV-1
- (2011) Rajesh Balagam et al. PLoS One
- Cross-Sectional Detection of Acute HIV Infection: Timing of Transmission, Inflammation and Antiretroviral Therapy
- (2011) Cynthia Gay et al. PLoS One
- Relationship between Functional Profile of HIV-1 Specific CD8 T Cells and Epitope Variability with the Selection of Escape Mutants in Acute HIV-1 Infection
- (2011) Guido Ferrari et al. PLoS Pathogens
- HIV-1 Vaccine Development After STEP
- (2010) Dan H. Barouch et al. Annual Review of Medicine
- Does Cytolysis by CD8+ T Cells Drive Immune Escape in HIV Infection?
- (2010) M. Balamurali et al. JOURNAL OF IMMUNOLOGY
- Estimation of the Initial Viral Growth Rate and Basic Reproductive Number during Acute HIV-1 Infection
- (2010) R. M. Ribeiro et al. JOURNAL OF VIROLOGY
- Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing
- (2010) Will Fischer et al. PLoS One
- Recombination Rate and Selection Strength in HIV Intra-patient Evolution
- (2010) Richard A. Neher et al. PLoS Computational Biology
- CD8+ Lymphocytes Control Viral Replication in SIVmac239-Infected Rhesus Macaques without Decreasing the Lifespan of Productively Infected Cells
- (2010) Nichole R. Klatt et al. PLoS Pathogens
- In Vivo CD8+ T-Cell Suppression of SIV Viremia Is Not Mediated by CTL Clearance of Productively Infected Cells
- (2010) Joseph K. Wong et al. PLoS Pathogens
- Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703–positive individuals and their transmission recipients
- (2009) Hayley Crawford et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection
- (2009) Nilu Goonetilleke et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Kinetics of Expansion of Epitope-Specific T Cell Responses during Primary HIV-1 Infection
- (2009) E. L. Turnbull et al. JOURNAL OF IMMUNOLOGY
- No evidence for competition between cytotoxic T-lymphocyte responses in HIV-1 infection
- (2009) H. R. Fryer et al. PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Variable Fitness Impact of HIV-1 Escape Mutations to Cytotoxic T Lymphocyte (CTL) Response
- (2009) Ryan M. Troyer et al. PLoS Pathogens
- Post-Step modifications for research on HIV vaccines
- (2008) Lawrence Corey et al. AIDS
- Selection dramatically reduces effective population size in HIV-1 infection
- (2008) Yi Liu et al. BMC EVOLUTIONARY BIOLOGY
- Lytic Granule Loading of CD8+ T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control
- (2008) Stephen A. Migueles et al. IMMUNITY
- Macaques vaccinated with live-attenuated SIV control replication of heterologous virus
- (2008) Matthew R. Reynolds et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Human Immunodeficiency Virus-Specific Gamma Interferon Enzyme-Linked Immunospot Assay Responses Targeting Specific Regions of the Proteome during Primary Subtype C Infection Are Poor Predictors of the Course of Viremia and Set Point
- (2008) C. M. Gray et al. JOURNAL OF VIROLOGY
- HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition
- (2008) T. Miura et al. JOURNAL OF VIROLOGY
- CD4+ Target Cell Availability Determines the Dynamics of Immune Escape and Reversion In Vivo
- (2008) J. Petravic et al. JOURNAL OF VIROLOGY
- Induction of Plasma (TRAIL), TNFR-2, Fas Ligand, and Plasma Microparticles after Human Immunodeficiency Virus Type 1 (HIV-1) Transmission: Implications for HIV-1 Vaccine Design
- (2008) N. Gasper-Smith et al. JOURNAL OF VIROLOGY
- Estimating the Impact of Vaccination on Acute Simian-Human Immunodeficiency Virus/Simian Immunodeficiency Virus Infections
- (2008) J. Petravic et al. JOURNAL OF VIROLOGY
- Functional Consequences of Human Immunodeficiency Virus Escape from an HLA-B*13-Restricted CD8+ T-Cell Epitope in p1 Gag Protein
- (2008) J. G. Prado et al. JOURNAL OF VIROLOGY
- Protective HLA Class I Alleles That Restrict Acute-Phase CD8+ T-Cell Responses Are Associated with Viral Escape Mutations Located in Highly Conserved Regions of Human Immunodeficiency Virus Type 1
- (2008) Y. E. Wang et al. JOURNAL OF VIROLOGY
- Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
- (2008) Jinyan Liu et al. NATURE
- The Evolutionary Selective Advantage of HIV-1 Escape Variants and the Contribution of Escape to the HLA-Associated Risk of AIDS Progression
- (2008) Becca Asquith PLoS One
- Vaccination and Timing Influence SIV Immune Escape Viral Dynamics In Vivo
- (2008) Liyen Loh et al. PLoS Pathogens
- Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
- (2008) B. F. Keele et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rates of HIV immune escape and reversion: implications for vaccination
- (2008) Miles P. Davenport et al. TRENDS IN MICROBIOLOGY
- Dynamics of Immune Escape during HIV/SIV Infection
- (2008) Christian L. Althaus et al. PLoS Computational Biology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started